Association of hidradenitis suppurativa and familial Mediterranean fever: A case series of 6 patients - 06/03/17
, Katia Stankovic Stojanovic a, 1, Claude Bachmeyer a, 1, Patricia Senet c, David Buob d, 1, Sylvain Audia e, Véronique Delcey f, Soraya Fellahi g, 1, Jean-Philippe Bastard g, 1, Fawaz Awad b, h, Marie Legendre h, Serge Amselem b, c, h, 1, Gilles Grateau a, b, 1Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 4 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Objectives |
Familial mediterranean fever (FMF) is the most common monogenic autoinflammatory disease. Hidradenitis suppurativa (HS) is an inflammatory cutaneous disease. Those diseases can occur simultaneously among the same individual. Our objective was to describe the features of patients displaying both FMF and HS.
Methods |
We screened the French adult FMF reference center for FMF patients with HS.
Results |
Six patients out of 151 (4%) with a median age of 36 years old were concerned. Among them, FMF was symptomatic at a median age of 11.5years old and colchicine was introduced at a median age of 20.5years old. HS was diagnosed at a median age of 31.5years old. An elderly patient displayed AA amyloidosis in the outcome of FMF, with a late diagnosis of HS, with response to anakinra. There was no temporal relation between FMF and HS attacks. Some patients had a persistent inflammatory syndrome under treatment.
Conclusion |
FMF and HS are both inflammatory diseases involving young patients, with HS possibly being an autoinflammatory disease. Although their association seems to be fortuitous, both can induce an important inflammation state that could lead to AA amyloidosis and require a close monitoring of clinical signs and acute-phase reactants. Anakinra was successful in treating the only patient with both HS, FMF and amyloidosis.
Le texte complet de cet article est disponible en PDF.Keywords : Familial Mediterranean fever, Hidradenitis suppurativa, Autoinflammatory syndrome, Colchicine, Interleukin-1 inhibitors, MEFV
Plan
Vol 84 - N° 2
P. 159-162 - mars 2017 Retour au numéro
Article précédent
- Neuralgic amyotrophy. An update
- Paul Seror
- Factors associated with knowledge and safety skills of arthritis patients receiving biologics: A survey of 677 patients
- Anne-Christine Rat, Bruno Fautrel, Elisabeth Flipon, Laure Gossec, Laurent Marguerie, Henri Nataf, Béatrice Pallot-Prades, Rose-Marie Poilvert, Valérie Royant, Fatiha Sadji, Christelle Sordet, Corinne Thevenot, Catherine Beauvais, French Society of Rheumatology Patient Education section
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?